St. Jude Medical Completes Purchase Of Spinal Modulation

(RTTNews) - Medical devices maker St. Jude Medical, Inc. (STJ) said it has completed the acquisition of Spinal Modulation, Inc., developer of the Axium Neurostimulator System. The acquisition was completed on May 1.

With the closing of the acquisition, St. Jude Medical has become the only medical device manufacturer in the world to offer radiofrequency ablation or RFA, spinal cord stimulation or SCS and dorsal root ganglion or DRG stimulation therapy solutions for the treatment of chronic pain.

The Axium system has CE Mark in the European Union for the management of chronic intractable pain and TGA approval in Australia for the management of chronic, intractable pain of the trunk and/or limbs.

In December 2014, Spinal Modulation announced that enrollment in its ACCURATE U.S. IDE trial had been completed and subsequently submitted its PMA application to the FDA in support of marketing approval in the U.S.

The full results from the ACCURATE Study will be presented at the 12th annual International Neuromodulation Society Congress, to be held in Montreal, Quebec, Canada from June 6-11, 2015.